Natascha Rodrigues
Research Subjects
Research Interests
Natascha Rodrigues has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Luiz Boechat
Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas , Manaus, Amazonas
1 shared publication - Beatriz Pessoa1 shared publication
- Carlos Soares1 shared publication
- Cecília Barroso1 shared publication
- David José Conceição Vila1 shared publication
- Emanuelly Maria Lima Barbosa
Programa de Educação Tutorial PET Medicina, Faculdade de Medicina, Universidade Federal do Amazonas
1 shared publication
Latest Publications
- Open Access
- 2 August 2020
- Published by MDPI AG in Preprints.org
SARS-CoV-2 and Covid-19 Immunopathogenesis
The coronavirus disease 2019 (COVID-19) is now a global pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Unlike other known coronaviruses, such as the Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 reveals new clinical, immunological, and pathologic features. The lymphocyte depletion, macrophage and neutrophil hyperactivation, cytokine dysregulation, thrombophilia, delayed antiviral response, and immune exhaustion are key immunological findings linked to the clinical progression of this disease. Understanding and identifying the underlying immunological basis of COVID-19 is crucial to designing effective therapies. Here, we provide an overview of immunopathogenesis driven by SARS-CoV-2 after its interactions with the immune system.
- 2 August 2020
- Published by MDPI AG in Preprints.org
Open AccessSARS-CoV-2 and Covid-19 Immunopathogenesis
The coronavirus disease 2019 (COVID-19) is now a global pandemic caused by the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Unlike other known coronaviruses, such as the Middle East respiratory syndrome coronavirus (MERS-CoV), SARS-CoV-2 reveals new clinical, immunological, and pathologic features. The lymphocyte depletion, macrophage and neutrophil hyperactivation, cytokine dysregulation, thrombophilia, delayed antiviral response, and immune exhaustion are key immunological findings linked to the clinical progression of this disease. Understanding and identifying the underlying immunological basis of COVID-19 is crucial to designing effective therapies. Here, we provide an overview of immunopathogenesis driven by SARS-CoV-2 after its interactions with the immune system.